This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Metabolic Syndrome in Patients With Bipolar Disorder

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We previously reported a 30% prevalence of themetabolic syndrome in the first 171 participants in our BipolarDisorder Center for Pennsylvanians study.1 However, theAmerican Heart Association and the National Heart, Lung, andBlood Institute have recently issued a scientific statement thathas suggested a modification of the diagnostic criteria for themetabolic syndrome as follows: (1) the threshold for serumlevels of impaired fasting glucose should be reduced from 110to 100 mg/dL; (2) the low high-density lipoprotein (HDL) cholesterolcriterion should be considered as endorsed also whenHDL cholesterol is within normal limits if the patient is undergoingdrug treatment for reduced HDL cholesterol; and (3) thehypertension criterion is endorsed also if only the systolicblood pressure or only the diastolic blood pressure is elevated(≥ 130 and ≥ 85 mm Hg, respectively).2 Therefore, we decidedto reevaluate the prevalence of the metabolic syndrome usingthe new diagnostic criteria in a considerably expanded sampleof 441 subjects (mean age = 44.4 years, SD = 15.3 years) withbipolar I disorder (N = 321), bipolar II disorder (N = 95), bipolardisorder not otherwise specified (N = 15), or schizoaffectivedisorder bipolar type (N = 10).’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Metabolic Disorder , Side Effects-Medication